These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18056771)

  • 1. An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits.
    Nesterova M; Bossis I; Wen F; Horvath A; Matyakhina L; Stratakis CA
    J Clin Endocrinol Metab; 2008 Feb; 93(2):565-71. PubMed ID: 18056771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.
    Basso F; Rocchetti F; Rodriguez S; Nesterova M; Cormier F; Stratakis CA; Ragazzon B; Bertherat J; Rizk-Rabin M
    Horm Metab Res; 2014 Nov; 46(12):883-8. PubMed ID: 25268545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.
    Briassoulis G; Keil MF; Naved B; Liu S; Starost MF; Nesterova M; Gokarn N; Batistatos A; Wu TJ; Stratakis CA
    Behav Brain Res; 2016 Jul; 307():1-10. PubMed ID: 26992826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
    Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
    Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
    Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
    Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters.
    Cazabat L; Ragazzon B; Varin A; Potier-Cartereau M; Vandier C; Vezzosi D; Risk-Rabin M; Guellich A; Schittl J; Lechêne P; Richter W; Nikolaev VO; Zhang J; Bertherat J; Vandecasteele G
    Hum Mol Genet; 2014 Mar; 23(5):1163-74. PubMed ID: 24122441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice.
    Liu S; Saloustros E; Mertz EL; Tsang K; Starost MF; Salpea P; Faucz FR; Szarek E; Nesterova M; Leikin S; Stratakis CA
    Hum Mol Genet; 2015 Nov; 24(21):6080-92. PubMed ID: 26246497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of novel PRKAR1A mutants that extend the predicted RIα protein sequence into the 3'-untranslated open reading frame: proteasomal degradation leads to RIα haploinsufficiency and Carney complex.
    Patronas Y; Horvath A; Greene E; Tsang K; Bimpaki E; Haran M; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E496-502. PubMed ID: 22205709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.
    Robinson-White A; Hundley TR; Shiferaw M; Bertherat J; Sandrini F; Stratakis CA
    Hum Mol Genet; 2003 Jul; 12(13):1475-84. PubMed ID: 12812976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRKAR1A gene analysis and protein kinase A activity in endometrial tumors.
    Tsigginou A; Bimpaki E; Nesterova M; Horvath A; Boikos S; Lyssikatos C; Papageorgiou C; Dimitrakakis C; Rodolakis A; Stratakis CA; Antsaklis A
    Endocr Relat Cancer; 2012 Aug; 19(4):457-62. PubMed ID: 22461635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between steroidogenesis, the cell cycle, and PKA in adrenocortical tumor cells.
    Rizk-Rabin M; Chaoui-Ibadioune S; Vaczlavik A; Ribes C; Polak M; Ragazzon B; Bertherat J
    Mol Cell Endocrinol; 2020 Jan; 500():110636. PubMed ID: 31678420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling.
    Almeida MQ; Muchow M; Boikos S; Bauer AJ; Griffin KJ; Tsang KM; Cheadle C; Watkins T; Wen F; Starost MF; Bossis I; Nesterova M; Stratakis CA
    Hum Mol Genet; 2010 Apr; 19(8):1387-98. PubMed ID: 20080939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex.
    Rhayem Y; Le Stunff C; Abdel Khalek W; Auzan C; Bertherat J; Linglart A; Couvineau A; Silve C; Clauser E
    J Biol Chem; 2015 Nov; 290(46):27816-28. PubMed ID: 26405036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
    Nadella K; Faucz FR; Stratakis CA
    Endocr Relat Cancer; 2020 Oct; 27(10):591-599. PubMed ID: 32738126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
    Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
    Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.